BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Executive Compensation
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) is a publicly traded company on the OTC, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BCLI
CIK: 1137883
Exchange: OTC
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Brightman Almagor Zohar & Co.
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerLiran Newman
Audit LocationTel Aviv, Israel
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001104659-26-097275 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-14 | FORM 8-K | 0001104659-26-097180 | View SEC Doc Filr Page |
| 8-K | 2026-07-30 | 2026-07-24 | FORM 8-K | 0001104659-26-088728 | View SEC Doc Filr Page |
| 4 | 2026-07-28 | 2026-07-24 | OWNERSHIP DOCUMENT | 0001104659-26-087588 | View SEC Doc Filr Page |
| 4 | 2026-07-28 | 2026-07-24 | OWNERSHIP DOCUMENT | 0001104659-26-087584 | View SEC Doc Filr Page |
| 3 | 2026-06-03 | 2026-05-25 | OWNERSHIP DOCUMENT | 0001104659-26-070209 | View SEC Doc Filr Page |
| EFFECT | 2026-06-02 | — | EFFECT Filing | 9999999995-26-001853 | View SEC Doc Filr Page |
| CORRESP | 2026-06-01 | — | CORRESP Filing | 0001104659-26-068906 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-02-26 | OWNERSHIP DOCUMENT | 0001104659-26-068339 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-02-26 | OWNERSHIP DOCUMENT | 0001104659-26-068338 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-02-26 | OWNERSHIP DOCUMENT | 0001104659-26-068337 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-02-26 | OWNERSHIP DOCUMENT | 0001104659-26-068336 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-02-26 | OWNERSHIP DOCUMENT | 0001104659-26-068335 | View SEC Doc Filr Page |
| 8-K | 2026-05-28 | 2026-05-25 | FORM 8-K | 0001104659-26-067474 | View SEC Doc Filr Page |
| UPLOAD | 2026-05-27 | — | UPLOAD Filing | 0000000000-26-005403 | View SEC Doc Filr Page |
| S-8 | 2026-05-21 | — | FORM S-8 | 0001104659-26-064632 | View SEC Doc Filr Page |
| S-1 | 2026-05-21 | — | S-1 | 0001104659-26-064628 | View SEC Doc Filr Page |
| 4 | 2026-05-20 | 2026-02-26 | OWNERSHIP DOCUMENT | 0001104659-26-064658 | View SEC Doc Filr Page |
| 4 | 2026-05-20 | 2026-02-26 | OWNERSHIP DOCUMENT | 0001104659-26-064657 | View SEC Doc Filr Page |
| 4 | 2026-05-20 | 2026-02-26 | OWNERSHIP DOCUMENT | 0001104659-26-064656 | View SEC Doc Filr Page |
| 4 | 2026-05-20 | 2026-02-26 | OWNERSHIP DOCUMENT | 0001104659-26-064653 | View SEC Doc Filr Page |
| 4 | 2026-05-20 | 2026-02-26 | OWNERSHIP DOCUMENT | 0001104659-26-064652 | View SEC Doc Filr Page |
| 4 | 2026-05-20 | 2026-02-26 | OWNERSHIP DOCUMENT | 0001104659-26-064650 | View SEC Doc Filr Page |
| 8-K | 2026-05-15 | 2026-05-15 | FORM 8-K | 0001104659-26-062766 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | 10-Q | 0001104659-26-062648 | View SEC Doc Filr Page |